Gary Lieberman analyst

Covered Stocks

Gary Lieberman

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Gary Lieberman is focused on the Healthcare sector with 8 price targets and ratings documented since 2017 spanning on 2 stocks. Previously, Gary Lieberman worked at WELLS FARGO. Analyst's average stock valuation to be materialised ratio is 100% with an average time for price targets to be met of 28 days.

Most recent stock forecast was given on DGX, Quest Diagnostics Incorporated at 20-Oct-2017.

Gary Lieberman best performing recommendations are on DGX (QUEST DIAGNOSTICS INCORPORATED).
The best stock recommendation documented was for DGX (QUEST DIAGNOSTICS INCORPORATED) at 10/12/2017. The price target of $88 was fulfilled within 49 days with a profit of $5.66 (6.87%) receiving and performance score of 1.4.

Average potential price target upside

Currently, out of the existing stock ratings of Gary Lieberman - 770 which are a Hold (68.44%), 190 which are a Sell (16.89%), 165 which are a Buy (14.67%)

DGX THC

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

165

$24.94 (17.81%)

165

10 days ago

26/30 (86.67%)

$17.35 (20.46%)

383

Hold

160

$19.94 (14.24%)

160

10 days ago

9/12 (75%)

$18.8 (18.11%)

268

Hold

154

$13.94 (9.95%)

146

2 months 15 days ago

11/13 (84.62%)

$20.35 (20.09%)

330

Hold

158

$17.94 (12.81%)

146

2 months 21 days ago

19/20 (95%)

$15.12 (15.48%)

226

Hold

140

$-0.06 (-0.04%)

129

5 months 6 days ago

15/16 (93.75%)

$17.88 (26.92%)

885

Show more analysts
DGX THC